169 related articles for article (PubMed ID: 28657744)
21. Novel (R)-6,6a,7,8,9,10-hexahydro-5H-pyrazino[1,2-a][1,n]naphthyridines as potent and selective agonists of the 5-HT
Schrader TO; Zhu X; Kasem M; Ren A; Liu C; Wu C; Dang H; Le M; Gatlin J; Chase K; Frazer J; Whelan KT; Grottick AJ; Hutton C; Barden J; Chen C; Ortiz A; Feichtinger K; Semple G
Bioorg Med Chem Lett; 2021 Apr; 38():127872. PubMed ID: 33636307
[TBL] [Abstract][Full Text] [Related]
22. CP-809,101, a selective 5-HT2C agonist, shows activity in animal models of antipsychotic activity.
Siuciak JA; Chapin DS; McCarthy SA; Guanowsky V; Brown J; Chiang P; Marala R; Patterson T; Seymour PA; Swick A; Iredale PA
Neuropharmacology; 2007 Feb; 52(2):279-90. PubMed ID: 16949622
[TBL] [Abstract][Full Text] [Related]
23. Tetrahydroquinoline-based tricyclic amines as potent and selective agonists of the 5-HT
Schrader TO; Kasem M; Ren A; Feichtinger K; Al Doori B; Wei J; Wu C; Dang H; Le M; Gatlin J; Chase K; Dong J; Whelan KT; Sage C; Grottick AJ; Semple G
Bioorg Med Chem Lett; 2016 Dec; 26(24):5877-5882. PubMed ID: 27864071
[TBL] [Abstract][Full Text] [Related]
24. A new class of 5-HT
Casey AB; Mukherjee M; McGlynn RP; Cui M; Kohut SJ; Booth RG
Br J Pharmacol; 2022 Jun; 179(11):2610-2630. PubMed ID: 34837227
[TBL] [Abstract][Full Text] [Related]
25. Identification of Optically Active Pyrimidine Derivatives as Selective 5-HT
Kim J; Jo H; Lee H; Choo H; Kim HJ; Pae AN; Cho YS; Min SJ
Molecules; 2017 Aug; 22(9):. PubMed ID: 28846591
[TBL] [Abstract][Full Text] [Related]
26. Synthesis and serotonin receptor affinities of a series of trans-2-(indol-3-yl)cyclopropylamine derivatives.
Vangveravong S; Kanthasamy A; Lucaites VL; Nelson DL; Nichols DE
J Med Chem; 1998 Dec; 41(25):4995-5001. PubMed ID: 9836617
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and SAR study of 4-arylpiperidines and 4-aryl-1,2,3,6-tetrahydropyridines as 5-HT₂C agonists.
Conway RJ; Valant C; Christopoulos A; Robertson AD; Capuano B; Crosby IT
Bioorg Med Chem Lett; 2012 Apr; 22(7):2560-4. PubMed ID: 22381048
[TBL] [Abstract][Full Text] [Related]
28. Agonist-directed trafficking of signalling at serotonin 5-HT2A, 5-HT2B and 5-HT2C-VSV receptors mediated Gq/11 activation and calcium mobilisation in CHO cells.
Cussac D; Boutet-Robinet E; Ailhaud MC; Newman-Tancredi A; Martel JC; Danty N; Rauly-Lestienne I
Eur J Pharmacol; 2008 Oct; 594(1-3):32-8. PubMed ID: 18703043
[TBL] [Abstract][Full Text] [Related]
29. Discovery of a lead series of potent benzodiazepine 5-HT
Ren A; Zhu X; Feichtinger K; Lehman J; Kasem M; Schrader TO; Wong A; Dang H; Le M; Frazer J; Unett DJ; Grottick AJ; Whelan KT; Morgan ME; Sage CR; Semple G
Bioorg Med Chem Lett; 2020 Mar; 30(5):126929. PubMed ID: 31952960
[TBL] [Abstract][Full Text] [Related]
30. We Need 2C but Not 2B: Developing Serotonin 2C (5-HT2C) Receptor Agonists for the Treatment of CNS Disorders.
Cheng J; Kozikowski AP
ChemMedChem; 2015 Dec; 10(12):1963-7. PubMed ID: 26507582
[TBL] [Abstract][Full Text] [Related]
31. Targeting the 5-HT2C Receptor in Biological Context and the Current State of 5-HT2C Receptor Ligand Development.
Wold EA; Wild CT; Cunningham KA; Zhou J
Curr Top Med Chem; 2019; 19(16):1381-1398. PubMed ID: 31288724
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and structure-activity relationships of N-benzyl phenethylamines as 5-HT2A/2C agonists.
Hansen M; Phonekeo K; Paine JS; Leth-Petersen S; Begtrup M; Bräuner-Osborne H; Kristensen JL
ACS Chem Neurosci; 2014 Mar; 5(3):243-9. PubMed ID: 24397362
[TBL] [Abstract][Full Text] [Related]
33. Pharmacological characterisation of the agonist radioligand binding site of 5-HT(2A), 5-HT(2B) and 5-HT(2C) receptors.
Knight AR; Misra A; Quirk K; Benwell K; Revell D; Kennett G; Bickerdike M
Naunyn Schmiedebergs Arch Pharmacol; 2004 Aug; 370(2):114-23. PubMed ID: 15322733
[TBL] [Abstract][Full Text] [Related]
34. Receptor interaction profiles of novel psychoactive tryptamines compared with classic hallucinogens.
Rickli A; Moning OD; Hoener MC; Liechti ME
Eur Neuropsychopharmacol; 2016 Aug; 26(8):1327-37. PubMed ID: 27216487
[TBL] [Abstract][Full Text] [Related]
35. Design and Synthesis of Bitopic 2-Phenylcyclopropylmethylamine (PCPMA) Derivatives as Selective Dopamine D3 Receptor Ligands.
Tan L; Zhou Q; Yan W; Sun J; Kozikowski AP; Zhao S; Huang XP; Cheng J
J Med Chem; 2020 May; 63(9):4579-4602. PubMed ID: 32282200
[TBL] [Abstract][Full Text] [Related]
36. Constitutive activity of serotonin 2C receptors at G protein-independent signaling: modulation by RNA editing and antidepressants.
Labasque M; Meffre J; Carrat G; Becamel C; Bockaert J; Marin P
Mol Pharmacol; 2010 Nov; 78(5):818-26. PubMed ID: 20699324
[TBL] [Abstract][Full Text] [Related]
37. Morphine-induced Straub tail reaction in mice treated with serotonergic compounds.
Belozertseva IV; Dravolina OA; Tur MA; Semina MG; Zvartau EE; Bespalov AY
Eur J Pharmacol; 2016 Nov; 791():1-7. PubMed ID: 27565217
[TBL] [Abstract][Full Text] [Related]
38. Novel 6,7,8,9-tetrahydro-5H-1,4,7,10a-tetraaza-cyclohepta[f]indene analogues as potent and selective 5-HT(2C) agonists for the treatment of metabolic disorders.
Tye H; Mueller SG; Prestle J; Scheuerer S; Schindler M; Nosse B; Prevost N; Brown CJ; Heifetz A; Moeller C; Pedret-Dunn A; Whittaker M
Bioorg Med Chem Lett; 2011 Jan; 21(1):34-7. PubMed ID: 21146986
[TBL] [Abstract][Full Text] [Related]
39. N-Benzyl-5-methoxytryptamines as Potent Serotonin 5-HT2 Receptor Family Agonists and Comparison with a Series of Phenethylamine Analogues.
Nichols DE; Sassano MF; Halberstadt AL; Klein LM; Brandt SD; Elliott SP; Fiedler WJ
ACS Chem Neurosci; 2015 Jul; 6(7):1165-75. PubMed ID: 25547199
[TBL] [Abstract][Full Text] [Related]
40. The identification of pyrimidine-diazabicyclo[3.3.0]octane derivatives as 5-HT2C receptor agonists.
Huck BR; Llamas L; Robarge MJ; Dent TC; Song J; Hodnick WF; Crumrine C; Stricker-Krongrad A; Harrington J; Brunden KR; Bennani YL
Bioorg Med Chem Lett; 2006 Jun; 16(11):2891-4. PubMed ID: 16546379
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
